Chemotherapeutic Treatment Options for Triple Negative Breast Cancer Lauren Barney April 17, 2013.
Terapia Neoadiuvante nella malattia HER-2 positiva: Trasferibilità nella pratica clinica Vincenzo Adamo UOC Terapie Integrate in Oncologia AOU Policlinico.
NSABP Neoadjuvant Chemotherapy and Axillary Staging Thomas B. Julian, MD, FACS Professor of Surgery - Drexel University College of Medicine Senior Surgical.
Current Situation of Breast Cancer Treatment in US Stefan Glück MD PhD Professor of Medicine Clinical Director Braman Family Breast Cancer Institute UMSylvester.
Chemotherapeutic Treatment Options for Triple Negative Breast Cancer
February 2014 Evolving Magazine
